tirzepatide como se administra Para qué sirve el Tirzepatida, el medicamento para adelgazar que llega a la Argentina Understanding Tirzepatide for Diabetes Management
Description
Retatrutide has not yet received marketing authorisation from the MHRA or EMA and remains under clinical investigation
Caution is warranted
The Harmony Outcomes Trial, conducted in 2018, investigated the use of 3050 mg albiglutide once-weekly subcutaneous injection in 9463 patients with T2DM for a median of 1.5 years
In 2026, that exclusion has loosened
doi: 10.2337/diabetes.46.5.785
